Braun Stacey Associates Inc Sarepta Therapeutics, Inc. Transaction History
Braun Stacey Associates Inc
- $2.29 Billion
- Q1 2025
A detailed history of Braun Stacey Associates Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Braun Stacey Associates Inc holds 65,857 shares of SRPT stock, worth $4.01 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
65,857
Previous 100,022
34.16%
Holding current value
$4.01 Million
Previous $12.2 Million
65.45%
% of portfolio
0.18%
Previous 0.49%
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
521Shares Held
85.9MCall Options Held
1.55MPut Options Held
1.37M-
Black Rock Inc. New York, NY10.3MShares$628 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$553 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$529 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$263 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$248 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.33B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...